Increased fracture risk in normocalcemic postmenopausal women with high parathyroid hormone levels: A 16-year follow-up study

Calcified Tissue International

Volumn 88, Issue 3, 2011, Pages 238-245

  Rejnmark, Lars ^a   Vestergaard, Peter ^a   Brot, Christine ^b   Mosekilde, Leif ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b HVIDOVRE HOSPITAL   (Denmark)

Author keywords

DXA; Fracture; PTH; PTHrP; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; PARATHYROID HORMONE; VITAMIN D;

ADULT; ARTICLE; BODY MASS; BONE DENSITY; BONE TURNOVER; CALCIUM BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FOLLOW UP; FRACTURE; HIGH RISK PATIENT; HOSPITAL DISCHARGE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; OSTEOPOROSIS; POSTMENOPAUSE; PRIORITY JOURNAL; RISK FACTOR; VERTEBRA FRACTURE; VITAMIN BLOOD LEVEL;

BONE DENSITY; CALCIUM; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; FRACTURES, BONE; HUMANS; MIDDLE AGED; NUTRITIONAL STATUS; PARATHYROID HORMONE; POSTMENOPAUSE; RISK FACTORS; TIME FACTORS; UP-REGULATION; VITAMIN D;

EID: 79954422983     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00223-010-9454-0     Document Type: Article

References (25)

1. R Eastell A Arnold ML Brandi EM Brown P D'Amour DA Hanley DS Rao MR Rubin D Goltzman SJ Silverberg SJ Marx M Peacock L Mosekilde R Bouillon EM Lewiecki 2009 Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop J Clin Endocrinol Metab 94 340 350 19193909 10.1210/jc.2008-1758 1:CAS:528:DC%2BD1MXhvFCqsrc%3D
2. F Saleh R Jorde J Sundsfjord E Haug Y Figenschau 2006 Causes of secondary hyperparathyroidism in a healthy population: the Tromsø study J Bone Miner Metab 24 58 64 16369900 10.1007/s00774-005-0647-y (Pubitemid 41821505)
3. P Lips 2001 Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications Endocr Rev 22 477 501 11493580 10.1210/er.22.4.477 1:CAS:528: DC%2BD3MXms1aksL0%3D (Pubitemid 32762324)
4. L Mosekilde 2005 Vitamin D and the elderly Clin Endocrinol (Oxf) 62 265 281 10.1111/j.1365-2265.2005.02226.x 1:CAS:528:DC%2BD2MXjtVersLw%3D (Pubitemid 40380406)
5. P Lips T Duong A Oleksik D Black S Cummings D Cox T Nickelsen 2001 A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial J Clin Endocrinol Metab 86 1212 1221 11238511 10.1210/jc.86.3.1212 1:CAS:528:DC%2BD3MXitFWnt7s%3D (Pubitemid 32323007)
6. A Malabanan IE Veronikis MF Holick 1998 Redefining vitamin D insufficiency Lancet 351 805 806 9519960 10.1016/S0140-6736(05)78933-9 1:STN:280:DyaK1c7nvVOrsA%3D%3D (Pubitemid 28112350)
7. MC Chapuy P Preziosi M Maamer S Arnaud P Galan S Hercberg PJ Meunier 1997 Prevalence of vitamin D insufficiency in an adult normal population Osteoporos Int 7 439 443 9425501 10.1007/s001980050030 1:STN:280:DyaK1c%2Fos1Kgug%3D%3D (Pubitemid 27443069)
8. B Dawson-Hughes SS Harris GE Dallal 1997 Plasma calcidiol, season, and serum parathyroid hormone concentrations in healthy elderly men and women Am J Clin Nutr 65 67 71 8988915 1:CAS:528:DyaK2sXjsFWlug%3D%3D (Pubitemid 27020461)
9. C Brot P Vestergaard N Kolthoff J Gram AP Hermann OH Sorensen 2001 Vitamin D status and its adequacy in healthy Danish perimenopausal women: relationships to dietary intake, sun exposure and serum parathyroid hormone Br J Nutr 86 Suppl 1 S97 S103 11520426 10.1079/BJN2001345 1:CAS:528: DC%2BD3MXnsFKrsLc%3D
10. L Rejnmark P Vestergaard C Brot L Mosekilde 2008 Parathyroid response to vitamin D insufficiency: relations to bone, body composition, and to life style characteristics Clin Endocrinol (Oxf) 69 29 35 10.1111/j.1365-2265.2008.03186.x 1:CAS:528:DC%2BD1cXptFykurw%3D (Pubitemid 351847277)
11. O Sahota K Gaynor RH Harwood DJ Hosking 2001 Hypovitaminosis D and "functional hypoparathyroidism"-the NoNoF (Nottingham Neck of Femur) study Age Ageing 30 467 472 11742774 10.1093/ageing/30.6.467 1:STN:280:DC%2BD38%2FnsVOhtQ%3D%3D (Pubitemid 34071485)
12. L Mosekilde 2008 Primary hyperparathyroidism and the skeleton Clin Endocrinol (Oxf) 69 1 19 10.1111/j.1365-2265.2007.03162.x 1:CAS:528: DC%2BD1cXptFykur4%3D (Pubitemid 351863591)
13. P Vestergaard CL Mollerup VG Frokjaer P Christiansen M Blichert-Toft L Mosekilde 2000 Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism BMJ 321 598 602 10977834 10.1136/bmj.321.7261.598 1:STN:280:DC%2BD3cvmvF2lsw%3D%3D
14. AC Looker ME Mussolino 2008 Serum 25-hydroxyvitamin D and hip fracture risk in older U.S. white adults J Bone Miner Res 23 143 150 17907920 10.1359/jbmr.071003 1:CAS:528:DC%2BD1cXhtVCmtLk%3D
15. SR Cummings WS Browner D Bauer K Stone K Ensrud S Jamal B Ettinger 1998 Endogenous hormones and the risk of hip and vertebral fractures among older women. Study of Osteoporotic Fractures Research Group [see comments] N Engl J Med 339 733 738 9731089 10.1056/NEJM199809103391104 1:CAS:528:DyaK1cXmt1Khurg%3D (Pubitemid 28417356)
16. AM Tromp ME Ooms C Popp-Snijders JC Roos P Lips 2000 Predictors of fractures in elderly women Osteoporos Int 11 134 140 10793871 10.1007/PL00004174 1:STN:280:DC%2BD3c3lsVensw%3D%3D (Pubitemid 30168798)
17. L Mosekilde AP Hermann NH Beck P Charles SP Nielsen OH Sorensen 1999 The Danish Osteoporosis Prevention Study (DOPS): project design and inclusion of 2000 normal perimenopausal women Maturitas 31 207 219 10340280 10.1016/S0378-5122(99)00006-7 1:STN:280:DyaK1M3ntFKguw%3D%3D (Pubitemid 29132822)
18. JC Souberbielle E Lawson-Body B Hammadi E Sarfati A Kahan C Cormier 2003 The use in clinical practice of parathyroid hormone normative values established in vitamin D-sufficient subjects J Clin Endocrinol Metab 88 3501 3504 12915625 10.1210/jc.2003-030097 1:CAS:528:DC%2BD3sXmsFOksL0%3D (Pubitemid 37034484)
19. JE Rossouw GL Anderson RL Prentice AZ LaCroix C Kooperberg ML Stefanick RD Jackson SA Beresford BV Howard KC Johnson JM Kotchen J Ockene 2002 Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial JAMA 288 321 333 12117397 10.1001/jama.288.3.321 1:CAS:528:DC%2BD38Xltlegs7k%3D (Pubitemid 34761611)
20. V Beral 2003 Breast cancer and hormone-replacement therapy in the Million Women Study Lancet 362 419 427 12927427 10.1016/S0140-6736(03)14596-5 1:CAS:528:DC%2BD3sXmt1ajsrw%3D (Pubitemid 36999703)
21. TF Andersen M Madsen J Jorgensen L Mellemkjoer JH Olsen 1999 The Danish National Hospital Register. A valuable source of data for modern health sciences Dan Med Bull 46 263 268 10421985 1:STN:280:DyaK1MzltVyrtw%3D%3D (Pubitemid 29299976)
22. MH Gault LL Longerich JD Harnett C Wesolowski 1992 Predicting glomerular function from adjusted serum creatinine Nephron 62 249 256 1436333 10.1159/000187054 1:CAS:528:DyaK3sXjsFeqsw%3D%3D
23. N Saquib D von Mählen C Garland E Barrett-Connor 2006 Serum 25-hydroxyvitamin D, parathyroid hormone, and bone mineral density in men: the Rancho Bernardo study Osteoporos Int 17 1734 1741 16967190 10.1007/s00198-006- 0191-1 1:CAS:528:DC%2BD28XhtFSnsLzM (Pubitemid 44607393)
24. HA Bischoff-Ferrari T Dietrich EJ Orav B Dawson-Hughes 2004 Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults Am J Med 116 634 639 15093761 10.1016/j.amjmed.2003.12.029 1:CAS:528:DC%2BD2cXjt1SisrY%3D (Pubitemid 38490539)
25. RP Heaney MS Dowell CA Hale A Bendich 2003 Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D J Am Coll Nutr 22 142 146 12672710 1:CAS:528:DC%2BD3sXjtlelsLw%3D (Pubitemid 36417827)